19/08/2026
Two weeks to go until our next ° Academy! 📣
What does it actually take for diabetes technology to move from innovation to real-world access?
On 2 September, we’ll explore Health Economics & Outcomes Research (HEOR) and the role evidence can play in reimbursement, market access, health policy and advocacy in diabetes care.
Joining us is Annette Mehler, Senior Manager, Government Affairs, Advocacy & Health Policy (EMEA) at Dexcom.
With more than a decade of experience in diabetes medtech, particularly continuous glucose monitoring (CGM), Annette brings extensive experience at the intersection of diabetes technology, evidence, policy and access.
Together, we’ll explore how HEOR works in practice, how evidence influences reimbursement and market access decisions, and where people with lived experience and diabetes advocates can contribute to meaningful change.
📅 Wednesday, 2 September 2026
🕛 12:00–13:30 CEST
💻 Online via Microsoft Teams
This Lunch & Learn is created especially for our ° voices community. 💙
Check your inbox for your invitation and registration link.
🔎 Search for the subject line:
“Updated Link: ° Academy – Lunch & Learn on HEOR”
And don’t forget to complete the short pre-session questionnaire to help shape the conversation around the topics that matter most to our community.
We look forward to learning together! 💙